FDA Inspection
Mid South Biologics, LLCMid South Biologics, LLC – FDA Inspection, Jun 17, 2016
Record Details
This FDA Inspection record concerns Mid South Biologics, LLC, with an inspection on June 17, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Mid South Biologics, LLC
- Inspection Date
- June 17, 2016
- Product Type
- Biologics
View Company Profile
ID · 838551ce-f7e4-41a6-a081-2b8a36ae71dd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 983193
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.290(b)Establishing a system
- 21 CFR 1271.200(c)Calibrated per established schedules
- 21 CFR 1271.180(a)Procedures to meet core CTGP
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mid South Biologics, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 16, 2018 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 26, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 2, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Mid South Biologics, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.